FDA Investigator Esther B Gamallo Herrera
Esther B Gamallo Herrera has conducted inspections on 7 sites in 1 countries as of 08 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
08 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Esther B Gamallo Herrera:
Alan P Kurtzberg,
Amanda L Fyles,
Amir Alavi,
Andrew Le,
Andy B Lee,
Arie C Menachem,
Arsen Karapetyan,
Babajide Michael Osunsanmi,
Binh T Nguyen,
Brian P Putz,
Brien C Fox,
Carla J Lundi,
Carolina D Vasquez,
Caryn M Mcnab,
Cassandra L Abellard,
Cathleen A Carr Sharpe,
Chelsea N Sealey,
Chorng M Cheng,
Christopher R Czajka,
Claudia Mperez Kasmarski,
Daniel J Roberts,
Darren S Brown,
Deborah A Greco,
Diane Cvan Leeuwen,
Diane R Weidley,
Donna Mwilliams Hill, PhD,
Finn A Slizza,
Gene D Arcy,
Heidy C Perales,
James M Timper Jr,
Jamie M Du,
Jasmine N Thompson,
Jocelyn E Massey,
Joey V Quitania,
John A Gonzalez,
Joshua P Wireman,
Katherine E Jacobitz,
Kathy Chiu,
Kathy Kuo,
Kenneth H Williams,
Kham Phommachanh,
Kim Lthomas Cruse,
Lakecha N Lewis,
Lillian S Wu,
Lilly O Barton,
Liming Zhang,
Linda Thai,
LT Richard A Lyght,
M Jasnethoson Thompson,
Marcus F Yambot,
Mark C Saale,
Maxyne T Lam,
Michael A Charles,
Michael D Garcia,
Minh D Phan,
Nicholas L Hunt,
Phillip L Toy,
Richmond K Yip,
Santiago Gallardo Johnson,
Sean P Desbrow,
Sonia R Peterson,
Sonya L Karsik, RAC,
Stephanie A Slater, MS,
Sue Lee Chan,
Taichun Qin, PhD,
Tamala P Bogan,
Tamala P Magee,
Terri L Dodds,
Thao T Kwan,
Tiara Nbrown Crosen,
Tracey T Duong,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Vasant G Malshet, PhD,
Virgilio F Pacio, CSO,
Yasamin Ameri,
Yumi J Hiramine,
Yvette E Guillermo,
Zachary A Bogorad
Esther B Gamallo Herrera's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2009 | FDA 483 | ACTA Laboratories Inc - Form 483, 2009-09-04 |
January, 2008 | FDA 483 | North American Science Associates, LLC - Form 483, 2008-01-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more